The issuance of the patent demonstrates Kyowa Hakko’s commitment to delivering premium science backed ingredients. NEW YORK, Oct. 9, 2024 /PRNewswire-PRWeb/ — Kyowa Hakko USA, Inc., under the Cognizin® brand, is proud to announce the granting of a method-of-use patent for citicoline or…
Kyowa Hakko USA Receives U.S. Patent for Cognizin® Citicoline, Cementing Its Position as the Gold Standard Ingredient for Cognitive Health
This post was originally published on this site